Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Jun Du, Shu-hua Wang, Qing Yang, Qian-qian Chen & Xin Yao. (2016) p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis. World Journal of Surgical Oncology 14:1.
Crossref
Crossref
Lujia Wang, Minwei Zhou, Chenchen Feng, Peng Gao, Guanxiong Ding, Zhongwen Zhou, Haowen Jiang, Zhong Wu & Qiang Ding. (2016) Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy. International Urology and Nephrology 48:4, pages 495-501.
Crossref
Crossref
Liang Cheng, Darrell D. Davison, Julia Adams, Antonio Lopez-Beltran, Lisha Wang, Rodolfo Montironi & Shaobo Zhang. (2014) Biomarkers in bladder cancer: Translational and clinical implications. Critical Reviews in Oncology/Hematology 89:1, pages 73-111.
Crossref
Crossref
Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology
679
706
.
Tomonori Habuchi. 2011. Bladder Tumors:. Bladder Tumors:
139
163
.
Catharine M Sturgeon, Michael J Duffy, Barry R Hofmann, Rolf Lamerz, Herbert A Fritsche, Katja Gaarenstroom, Johannes Bonfrer, Thorsten H Ecke, H Barton Grossman, Peter Hayes, Ralf-Thorsten Hoffmann, Seth P Lerner, Florian Löhe, Johanna Louhimo, Ihor Sawczuk, Kazuhisa Taketa & Eleftherios P Diamandis. (2010) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers. Clinical Chemistry 56:6, pages e1-e48.
Crossref
Crossref
İpek Işık Gönül, Nalan Akyürek, Ayşe Dursun & Bora Küpeli. (2008) Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder. Pathology - Research and Practice 204:10, pages 707-717.
Crossref
Crossref
Sven Gunia, Matthias May, Katharina Scholmann, Stephan Störkel, Bernd Hoschke, Stefan Koch, Manfred Dietel & Glen Kristiansen. (2008) Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer. Virchows Archiv 453:2, pages 165-170.
Crossref
Crossref
Elena López-Knowles, Silvia Hernández, Manolis Kogevinas, Josep Lloreta, Alex Amorós, Adonina Tardón, Alfredo Carrato, Sirish Kishore, Consol Serra, Núria Malats & Francisco X. Real. (2006) The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors. Clinical Cancer Research 12:20, pages 6029-6036.
Crossref
Crossref
Andriy O. Yurakh, David Ramos, Silvia Calabuig-Fariñas, José Antonio López-Guerrero, José Rubio, Eduardo Solsona, Alina M. Romanenko, Alexander F. Vozianov, Antonio Pellin & Antonio Llombart-Bosch. (2006) Molecular and Immunohistochemical Analysis of the Prognostic Value of Cell-Cycle Regulators in Urothelial Neoplasms of the Bladder. European Urology 50:3, pages 506-515.
Crossref
Crossref
. 2006. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry
509
610
.
Tomonori Habuchi, Michael Marberger, Michael J. Droller, George P. HemstreetIIIIII, H. Barton Grossman, Jack A. Schalken, Bernd J. Schmitz-Dräger, William M. Murphy, Aldo V. Bono, Peter Goebell, Robert H. Getzenberg, Stefan H. Hautmann, Edward Messing, Yves Fradet & Vinata B. Lokeshwar. (2005) Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 66:6, pages 64-74.
Crossref
Crossref
JOHN JOSEPH MCKNIGHT, SAMUEL B. GRAY, HUGH F. O’KANE, SAMUEL R. JOHNSTON & KATE E. WILLIAMSON. (2005) APOPTOSIS AND CHEMOTHERAPY FOR BLADDER CANCER. Journal of Urology 173:3, pages 683-690.
Crossref
Crossref
M. Retz & J. Lehmann. 2005. Blasenkarzinom. Blasenkarzinom
27
65
.
NORM D. SMITH, JONATHAN N. RUBENSTEIN, SCOTT E. EGGENER & JAMES M. KOZLOWSKI. (2003) The p53 Tumor Suppressor Gene and Nuclear Protein: Basic Science Review and Relevance in the Management of Bladder Cancer. Journal of Urology 169:4, pages 1219-1228.
Crossref
Crossref
Burkhard Helpap, Bernd J. Schmitz-Dräger, Peter W. Hamilton, Giovanni Muzzonigro, Andrea B. Galosi, Karl H. Kurth, David Lubaroff, David J. Waters & Michael J. Droller. (2003) Molecular pathology of non-invasive urothelial carcinomas (part I). Virchows Archiv 442:4, pages 309-316.
Crossref
Crossref
Sun I.l Kim, Soo Mee Kwon, Young Sig Kim & Sung Joon Hong. (2002) Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer. Urology 60:5, pages 816-821.
Crossref
Crossref
MARK S. SOLOWAY, MARIO SOFER & ANIL VAIDYA. (2002) Contemporary Management Of Stage T1 Transitional Cell Carcinoma Of The Bladder. The Journal of Urology, pages 1573-1583.
Crossref
Crossref
Mark S. Soloway, Mario Sofer & Anil Vaidya. (2002) Contemporary Management Of Stage T1 Transitional Cell Carcinoma Of The Bladder. Journal of Urology 167:4, pages 1573-1583.
Crossref
Crossref
J.L. Moyano calvo, J.M. Poyato galán, A. Ortíz gamiz, A. Molina carranza, J.J. Zerpa railey, H. Toro cepeda, D. Sánchez-barriga peña, J. Castiñeiras fernández, M. De miguel rodríguez & H. Galera davidson. (2001) Determinación de ploidía de adn mediante citometría de flujo, índice ki-67 y sobre-expresión de proteína p53 en 121 carcinomas superficiales de vejiga t1. estudio retrospectivo. 2ª parte: valor pronóstico y utilidad en la indicación de tratamiento profiláctico con bcg. Actas Urológicas Españolas 25:1, pages 32-45.
Crossref
Crossref
Catherine A Reznikoff, Somdatta Sarkar, Knut P Jülicher, Melissa S Burger, Jairaj A Puthenveettil, David F Jarrard & Michael A Newton. (2000) Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urologic Oncology: Seminars and Original Investigations 5:5, pages 191-203.
Crossref
Crossref
Farhang Rabbani & Carlos Cordon-Cardo. (2000) MUTATION OF CELL CYCLE REGULATORS AND THEIR IMPACT ON SUPERFICIAL BLADDER CANCER. Urologic Clinics of North America 27:1, pages 83-102.
Crossref
Crossref
Aria F. Olumi. (2000) A CRITICAL ANALYSIS OF THE USE OF p53 AS A MARKER FOR MANAGEMENT OF BLADDER CANCER. Urologic Clinics of North America 27:1, pages 75-82.
Crossref
Crossref
M. De Miguel Rodríguez, H. Galera Davidson, J.L. Moyano Calvo, A. Ortiz Gamiz, J.M. Poyato Galán, E. Sánchez Sánchez, E. Blanco Palenciano, J.M. Arribas Rodríguez & J. Castiñeiras Fernández. (2000) Determinación de ploidía de adn mediante citometría de flujo, índice ki-67 y sobreexpresión de proteína p53 en 121 carcinomas superficiales de vejiga t1. estudio retrospectivo correlación con las variables clásicas. Actas Urológicas Españolas 24:10, pages 785-795.
Crossref
Crossref
J. Álvarez kindelán, A. López-beltrán & M.J. Requena tapia. (2000) Biología molecular en el cáncer vesical. Actas Urológicas Españolas 24:8, pages 604-625.
Crossref
Crossref